EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
152 hedge funds and large institutions have $328M invested in Eagle Pharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 48 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
152
Holders Change
-1
Holders Change %
-0.65%
% of All Funds
2.45%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
20
Increased
59
Reduced
48
Closed
19
Calls
$1.78M
Puts
$15K
Net Calls
+$1.77M
Net Calls Change
-$1.83M
Top Buyers
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
$35.9M |
| 2 |
JPMorgan Chase & Co
New York
|
$3.26M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
$6.77M |
| 4 |
Millennium Management
New York
|
$2.62M |
| 5 |
Citadel Advisors
Miami,
Florida
|
$3.32M |
